Clinical Trial Update: Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal Carcinomatosis [Phase 1]

View source ↗

Summary

Phase 1 study of Radspherin in recurrent ovarian cancer with peritoneal carcinomatosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Carcinomatosis

Drugs mentioned

• Radspherin

Snippet

Sponsor: Oncoinvent Solutions AS | Conditions: Peritoneal Carcinomatosis, Ovarian Cancer | Phase 1 | Status: COMPLETED